Hanmi Pharm Signs Exclusive Licensing Deal with Genentech for Novel Obesity Therapy HM17321, a proprietary UCN2 (urocortin-2) analog, is being developed as a treatment… CISION PRNewswireAugust 24, 2026
IBM and the USTA Introduce New AI-Powered Fan Experiences for 2026 US Open NEW YORK, Aug. 24, 2026 /PRNewswire/ — IBM (NYSE: IBM) and the… CISION PRNewswireAugust 24, 2026
IBM Study: Sports Fans Want Streamlined Digital Experiences as Platform Choices Expand AI use among surveyed sports fans increased in 2026, with accuracy driving… CISION PRNewswireAugust 24, 2026
Press ReleaseNew US$22 Million Education Lifeline for Crisis-Affected Children in Sudan New three-year investment will reach nearly 200,000 crisis-affected children and adolescents, helping… CISION PRNewswireAugust 24, 2026
Press ReleaseSoftcare Reports 46% Interim Profit Growth as Emerging-Market Momentum Continues, Payout Ratio Rises to Approximately 66% HONG KONG, Aug. 24, 2026 /PRNewswire/ — Softcare Limited ("Softcare" or the… CISION PRNewswireAugust 24, 2026
Press ReleaseLONGi at UNCCD COP17: Li Zhenguo Explains Two Technological Pathways for PV-Powered Food Security ULAANBAATAR, Mongolia, Aug. 24, 2026 /PRNewswire/ — From August 17 to 28,… CISION PRNewswireAugust 24, 2026
Press ReleaseOneSG61 with Antica Unites Community Inclusion, Youth Development and International Sporting Excellence Two-day community carnival and the Inaugural ANTICA Singapore International Challenge 2026 bring… CISION PRNewswireAugust 24, 2026
Press Releaseimin Pursues White-Label Partnerships to Expand into Japan, Taiwan and Southeast Asia Twave, operator of imin: "In discussions with financial groups and digital banks… CISION PRNewswireAugust 24, 2026